Acta Med. 2025, 68: 123-128

https://doi.org/10.14712/18059694.2026.2

Hyperlipidemia Associated Oxidative Stress and Its Impact on Bone Regeneration and Dental Implant Osseointegration

Amalia KoutsoupiaaID, Eleni KottiaID, Kalliopi TopouziaID, Maria KateriaID, Panagiotis KafasbID

aDental Students, School of Dentistry, Aristotle University of Thessaloniki, Greece
bDepartment of Oral Surgery and Radiology, School of Dentistry, Aristotle University of Thessaloniki, Greece

Received September 17, 2025
Accepted December 2, 2025

References

1. Sun H, Meng S, Chen J, Wan Q. Effects of Hyperlipidemia on Osseointegration of Dental Implants and Its Strategies. J Funct Biomater. 2023 Mar 30; 14(4): 194. <https://doi.org/10.3390/jfb14040194> <PubMed>
2. Pirih F, Lu J, Ye F, et al. Adverse effects of hyperlipidemia on bone regeneration and strength. Journal of Bone and Mineral Research. 2012 Feb 1; 27(2): 309–18. <https://doi.org/10.1002/jbmr.541> <PubMed>
3. Wang X, Qu Z, Zhao S, Luo L, Yan L. Wnt/β-catenin signaling pathway: proteins’ roles in osteoporosis and cancer diseases and the regulatory effects of natural compounds on osteoporosis. Mol Med. 2024 Oct 28; 30(1): 193. <https://doi.org/10.1186/s10020-024-00957-x> <PubMed>
4. Artigas N, Ureña C, Rodríguez-Carballo E, Rosa JL, Ventura F. Mitogen-activated Protein Kinase (MAPK)-regulated Interactions between Osterix and Runx2 Are Critical for the Transcriptional Osteogenic Program. J Biol Chem. 2014 Sept; 289(39): 27105–17. <https://doi.org/10.1074/jbc.M114.576793> <PubMed>
5. Sims NA. Cell-specific paracrine actions of IL-6 family cytokines from bone, marrow and muscle that control bone formation and resorption. Int J Biochem Cell Biol. 2016 Oct; 79: 14–23. <https://doi.org/10.1016/j.biocel.2016.08.003>
6. Cao JJ. Effects of obesity on bone metabolism. J Orthop Surg Res. 2011; 6(1): 30. <https://doi.org/10.1186/1749-799X-6-30> <PubMed>
7. Ali F, Ranneh Y, Ismail A, Vaes B. Impaired of a non-DNA dependent methylation status decides the fat decision of bone marrow-derived C3H10T1/2 stem cell. SpringerPlus. 2013 Dec; 2(1): 590. <https://doi.org/10.1186/2193-1801-2-590> <PubMed>
8. Huang X, Chen W, Gu C, et al. Melatonin suppresses bone marrow adiposity in ovariectomized rats by rescuing the imbalance between osteogenesis and adipogenesis through SIRT1 activation. J Orthop Translat. 2023 Jan; 38: 84–97. <https://doi.org/10.1016/j.jot.2022.10.002> <PubMed>
9. Hutchings G, Moncrieff L, Dompe C, et al. Bone Regeneration, Reconstruction and Use of Osteogenic Cells; from Basic Knowledge, Animal Models to Clinical Trials. J Clin Med. 2020 Jan 4; 9(1): 139. <https://doi.org/10.3390/jcm9010139> <PubMed>
10. Soltanoff CS, Yang S, Chen W, Li YP. Signaling Networks that Control the Lineage Commitment and Differentiation of Bone Cells. Crit Rev Eukar Gene Expr. 2009; 19(1): 1–46. <https://doi.org/10.1615/CritRevEukarGeneExpr.v19.i1.10>
11. Lang J, Morya VK, Kwak MK, Park SH, Noh KC. Molecular crosstalk in SP7-mediated osteogenesis: Regulatory mechanisms and therapeutic potential. Osteoporosis Sarcopenia. 2025 June; 11(2): 31–7. <https://doi.org/10.1016/j.afos.2025.04.003> <PubMed>
12. Luo J, Li L, Shi W, Xu K, Shen Y, Dai B. Oxidative stress and inflammation: roles in osteoporosis. Front Immunol. 2025 Aug 12; 16: 1611932. <https://doi.org/10.3389/fimmu.2025.1611932> <PubMed>
13. Ge C, Cawthorn WP, Li Y, Zhao G, MacDougald OA, Franceschi RT. Reciprocal Control of Osteogenic and Adipogenic Differentiation by ERK/MAP Kinase Phosphorylation of Runx2 and PPARγ Transcription Factors. J Cell Physiol. 2016 Mar; 231(3): 587–96. <https://doi.org/10.1002/jcp.25102> <PubMed>
14. Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL. Divergent Effects of Selective Peroxisome Proliferator-Activated Receptor-γ2 Ligands on Adipocyte Versus Osteoblast Differentiation. Endocrinology. 2002 June 1; 143(6): 2376–84. <https://doi.org/10.1210/endo.143.6.8834>
15. Valenti MT, Garbin U, Pasini A, et al. Role of Ox-PAPCs in the Differentiation of Mesenchymal Stem Cells (MSCs) and Runx2 and PPARγ2 Expression in MSCs-Like of Osteoporotic Patients. Rota M, editor. PLoS ONE. 2011 June 3; 6(6): e20363. <https://doi.org/10.1371/journal.pone.0020363> <PubMed>
16. Alekos NS, Moorer MC, Riddle RC. Dual Effects of Lipid Metabolism on Osteoblast Function. Front Endocrinol. 2020 Sept 23; 11: 578194. <https://doi.org/10.3389/fendo.2020.578194> <PubMed>
17. Xiao Y, Zhang S, Ye Y, Chen J, Xu Y. Geniposide suppressed OX-LDL-induced osteoblast apoptosis by regulating the NRF2/NF-κB signaling pathway. J Orthop Surg Res. 2023 Aug 30; 18(1): 641. <https://doi.org/10.1186/s13018-023-04125-5> <PubMed>
18. Xu J, Yu L, Liu F, Wan L, Deng Z. The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review. Front Immunol. 2023 July 5; 14: 1222129. <https://doi.org/10.3389/fimmu.2023.1222129> <PubMed>
19. Chen J, Lan Y, He Y, et al. 99Tc-MDP-induced human osteoblast proliferation, differentiation and expression of osteoprotegerin. Mol Med Rep. 2017; 16: 1801–9. <https://doi.org/10.3892/mmr.2017.6839> <PubMed>
20. Huang J, Zhao L, Xing L, Chen D. MicroRNA-204 Regulates Runx2 Protein Expression and Mesenchymal Progenitor Cell Differentiation. Stem Cells. 2010 Feb 1; 28(2): 357–64. <https://doi.org/10.1002/stem.288> <PubMed>
21. Gamie Z, Korres N, Leonidou A, Gray AC, Tsiridis E. Sclerostin mono- clonal antibodies on bone metabolism and fracture healing. Expert Opin Investig Drugs. 2012 Oct; 21(10): 1523–34. <https://doi.org/10.1517/13543784.2012.713936>
22. Li P, Alenazi KKK, Dally J, Woods EL, Waddington RJ, Moseley R. Role of oxidative stress in impaired type II diabetic bone repair: scope for antioxidant therapy intervention? Front Dent Med. 2024 Oct 14; 5: 1464009. <https://doi.org/10.3389/fdmed.2024.1464009> <PubMed>
23. Endale HT, Tesfaye W, Mengstie TA. ROS induced lipid peroxidation and their role in ferroptosis. Front Cell Dev Biol. 2023 Aug 1; 11: 1226044. <https://doi.org/10.3389/fcell.2023.1226044> <PubMed>
24. Wang YB, Li ZP, Wang P, et al. Iron dysregulation, ferroptosis, and oxidative stress in diabetic osteoporosis: Mechanisms, bone metabolism disruption, and therapeutic strategies. World J Diabetes [Internet]. 2025 June 15 [cited 2025 Aug 30]; 16(6). Available online: https://www.wjgnet.com/1948-9358/full/v16/i6/106720.htm. <https://doi.org/10.4239/wjd.v16.i6.106720> <PubMed>
25. Drakou A, Kaspiris A, Vasiliadis E, Evangelopoulos DS, Koulalis D, Lenti A. Oxidative Stress and Bone Remodeling: An Updated Review. Ann Case Report [Internet]. 2025 Feb 3 [cited 2025 Aug 30]; 10(1). Available online: https://www.gavinpublishers.com/article/view /oxidative-stress-and-bone-remodeling-an-updated-review-. <https://doi.org/10.29011/2574-7754.102174>
26. Cooke AA, Connaughton RM, Lyons CL, McMorrow AM, Roche HM. Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome. Eur J Pharmacol. 2016 Aug; 785: 207–14. <https://doi.org/10.1016/j.ejphar.2016.04.021>
27. Lencel P, Delplace S, Hardouin P, Magne D. TNF-α stimulates alkaline phosphatase and mineralization through PPARγ inhibition in human osteoblasts. Bone. 2011 Feb 1; 48(2): 242–9. <https://doi.org/10.1016/j.bone.2010.09.001>
28. Lim AC, Courtney KE, Moallem NR, Allen Jr. VC, Leventhal AM, Ray LA. A Brief Smoking Cessation Intervention for Heavy Drinking Smokers: Treatment Feasibility and Acceptability. Front Psychiatry. 2018 Aug 10; 9: 362. <https://doi.org/10.3389/fpsyt.2018.00362> <PubMed>
29. Hasan B, Nayfeh T, Alzuabi M, et al. Weight Loss and Serum Lipids in Overweight and Obese Adults: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2020 Dec 1; 105(12): 3695–703. <https://doi.org/10.1210/clinem/dgaa673>
30. Sendyk DI, Deboni MCZ, Pannuti CM, Naclério‐Homem MG, Wennerberg A. The influence of statins on osseointegration: a systematic review of animal model studies. J Oral Rehabil. 2016 Nov; 43(11): 873–82. <https://doi.org/10.1111/joor.12438>
31. Altanam SY, Darwish N, Bakillah A. Exploring the Interplay of Antioxidants, Inflammation, and Oxidative Stress: Mechanisms, Therapeutic Potential, and Clinical Implications. Diseases. 2025 Sep 22; 13(9): 309. <https://doi.org/10.3390/diseases13090309> <PubMed>
32. Huang J, Zhao L, Fan Y, et al. The microRNAs miR-204 and miR-211 maintain joint homeostasis and protect against osteoarthritis progression. Nat Commun. 2019 June 28; 10(1): 2876. <https://doi.org/10.1038/s41467-019-10753-5> <PubMed>
33. Nakasa T, Yoshizuka M, Usman M, Mahmoud E, Ochi M. MicroRNAs and Bone Regeneration. Curr Genomics. 2015 Sept 7; 16(6): 441–52. <https://doi.org/10.2174/1389202916666150817213630> <PubMed>
34. Huang M, Wang C, Li P, Lu H, Li A, Xu S. Role of immune dysregulation in peri-implantitis. Front Immunol. 2024 Nov 1; 15: 1466417. <https://doi.org/10.3389/fimmu.2024.1466417> <PubMed>
35. Mijiritsky E, Ferroni L, Gardin C, et al. Presence of ROS in Inflammatory Environment of Peri-Implantitis Tissue: In Vitro and In Vivo Human Evidence. J Clin Med. 2019 Dec 23; 9(1): 38. <https://doi.org/10.3390/jcm9010038> <PubMed>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive